Presentation Information
[1-MO4-5]Theranostics using [18F]PSMA-1007 and [211At]PSMA-5: Alpha-PS1 trial for refractory mCRPC
Tadashi Watabe1、Koji Hatano1、Sadahiro Naka2、Hidetaka Sasaki2、Takashi Kamiya2、Yoshifumi Shirakami1、Jens Cardinale3、Frederik Giesel3、Kayako Isohashi1、Norio Nonomura1、Noriyuki Tomiyama1 (1.The University of Osaka, Osaka, Japan、2.The University of Osaka Hospital, Osaka, Japan、3.Dusseldorf University)